Substituted hydroxyethylamine aspartyl protease inhibitors
US7858642B2 · kind B2 · utility
3Cited by
28References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 2009 |
| Grant date | Dec 28, 2010 |
| Priority date | — |
| Expiry date | Mar 3, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to novel compounds and also to methods of treating at least one disease, disorder, or condition associated with amyloidosis using such compounds. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.